Monocyte to macrophage differentiation-associated 2 (MMD2)
Target
MMD2
Molecular classification
Receptor (specifically, progestin and adipoQ receptor family), Seven-transmembrane domain protein (structurally similar to G protein-coupled receptors, though there is debate about canonical coupling), Membrane protein (localized to Golgi apparatus), Ras signaling modulator (functionally and structurally related to regulatory proteins in signal transduction)
01
Overview
Monocyte to macrophage differentiation-associated 2 (MMD2), also known as PAQR10, is a membrane protein of the progestin and adipoQ receptor family characterized by seven transmembrane domains and evolutionary conservation with hemolysin-like bacterial proteins. It is localized to the Golgi apparatus and acts as a modulator of Ras signaling, most notably stimulating ERK phosphorylation and the differentiation of cells such as PC12 in response to Ras pathway activation. Functional genomic studies implicate MMD2 in macrophage differentiation, immune system regulation, and disease susceptibility—particularly in chronic inflammatory conditions like Crohn's disease. Other members of the PAQR family are important in metabolic and sex steroid signaling, but MMD2/PAQR10 are distinctive for their role in Golgi-localized control of Ras activity. Research into therapeutic modulation of MMD2 is ongoing, with its function linked to pathways central to immunity, cell growth, and the development of malignancy.
Other names
PAQR10Monocyte to macrophage differentiation factor 2Progestin and adipoQ receptor family member 10Monocyte-to-macrophage differentiation-associated protein 2
02
Mechanism of action
Drugs would potentially act by modulating Ras signaling in the Golgi apparatus—either through interaction with MMD2/PAQR10’s seven-transmembrane domains or altering its interaction with Ras or RasGRP1.
03
Biological functions
Macrophage development and differentiationModulation of Ras signaling in the Golgi apparatusRegulation of ERK pathway activityCell growth control (studied as a growth suppressor in some species)Potential roles in metabolism and apoptosis (speculated due to PAQR family connections, but not directly confirmed for MMD2/PAQR10)
04
Disease associations
Inflammation (linked to innate immunity and Crohn’s disease susceptibility through macrophage regulation)Cancer (potential involvement via Ras/ERK pathway modulation)Muscular dystrophy (GeneCards reports association with Miyoshi Muscular Dystrophy 2/3, though this is less established in the literature)Other immune-related diseases (based on macrophage/innate immune dysregulation)
05
Safety considerations
Off-target effects from modulation of Ras signaling, which is broadly implicated in cell growth, proliferation, and differentiation (possible cancer risk, abnormal cell growth)Potential risk associated with broad manipulation of macrophage differentiation or immune cell function (immune dysregulation)No specific safety data for targeted MMD2 inhibition or activation are available.
06
Interacting drugs
None explicitly reported in the search results (there is currently no clinically approved drug targeting MMD2/PAQR10 directly; research is ongoing in the context of Ras pathway modulators.)
07
Biomarkers
Variants in MMD2 may be considered biomarkers for innate immunity status or disease susceptibility in chronic inflammation (such as Crohn’s disease)There are no well-established clinical biomarkers tied to drug efficacy or patient selection for this target at present.
Beyond the preview
Go deeper on Monocyte to macrophage differentiation-associated 2 (MMD2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Monocyte to macrophage differentiation-associated 2 (MMD2).